Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 95.67 USD -3.01% Market Closed
Market Cap: 8.2B USD

Healthequity Inc
Investor Relations

In the world of healthcare finance, Healthequity Inc. plays a vital role as a bridge between individuals and their healthcare savings. Founded in 2002 and headquartered in Draper, Utah, the company specializes in administering Health Savings Accounts (HSAs) and other consumer-directed benefits. By empowering more than 12 million members to make informed healthcare spending decisions, Healthequity stands at the intersection of finance and healthcare. With an impressive technological backbone, it provides seamless integration solutions for employers, health plans, and financial institutions, ensuring that account holders have easy access to their funds and efficient management tools. This integration allows individuals to save for future medical expenses tax-free, a compelling proposition as healthcare costs continue to rise.

Healthequity's revenue generation is primarily tied to administrative fees and the interest income from the funds in the accounts it oversees. By offering custodial services for HSAs, Flexible Spending Accounts (FSAs), Health Reimbursement Arrangements (HRAs), and other benefit plans, it retains a steady stream of service fees from both employers and account holders. Furthermore, Healthequity generates revenue through partnerships with employers and insurance firms, who often incentivize HSA adoption as part of their employee health benefits packages. By capitalizing on its technological prowess and customer-centric approach, Healthequity fosters a robust growth model that capitalizes on the evolving nexus of healthcare and financial planning.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Dec 3, 2025
AI Summary
Q3 2026

Revenue Growth: HealthEquity reported Q3 revenue up 7% year-over-year, with strong growth across key metrics.

Margin Expansion: Gross margin rose to 71% (up from 66% last year) and adjusted EBITDA margin reached 44%, highlighting improved operational efficiency.

Net Income Surge: Q3 net income jumped 806% YoY to $51.7 million, primarily due to the absence of a prior year's legal settlement; non-GAAP net income rose 26%.

Guidance Raised: Fiscal 2026 guidance for revenue, net income, and adjusted EBITDA was raised, reflecting management's confidence.

HSA Growth: Total HSA accounts surpassed 10 million, with HSA assets up 15% YoY to $34 billion and invested assets rising 29% to $17.5 billion.

Marketplace & AI Investments: Early adoption of the HealthEquity Marketplace and AI-driven member services are driving better experiences and cost reductions.

Strong Cash Flow & Buybacks: The company generated $339 million cash from operations in nine months and repurchased $94 million in shares; $259 million remains authorized.

Optimistic Outlook: Management remains optimistic about new account growth in Q4, driven by ACA-related opportunities and continued employer adoption.

Key Financials
Revenue
$1.302–$1.312B (fiscal 2026 guidance)
Net Income
$51.7M (Q3)
EPS
$0.59 (Q3); $2.24–$2.33 (fiscal 2026 guidance)
Adjusted EBITDA
$141.8M (Q3)
Gross Margin
71% (Q3)
Adjusted EBITDA Margin
44% (Q3)
Service Revenue
$120.3M (Q3)
Custodial Revenue
$159.1M (Q3)
Interchange Revenue
$42.8M (Q3)
Cash on Hand
$309M (as of October 31, 2025)
Cash Flow from Operations
$339M (first 9 months fiscal 2026)
Debt Outstanding
$982M (as of October 31, 2025)
Share Repurchases
$94M repurchased in Q3; $259M remaining authorization
Total Accounts
Over 17 million (Q3)
HSA Accounts
Over 10 million (Q3)
HSA Assets
$34B (Q3)
HSA Invested Assets
$17.5B (Q3)
Annualized Yield on HSA Cash
3.53% (Q3)
Fraud Costs
$0.3M (Q3)
Other Earnings Calls

Management

Mr. Jon Kessler
President, CEO & Director
No Bio Available
Dr. Stephen D. Neeleman
Founder & Vice Chairman
No Bio Available
Mr. James M. Lucania
CFO & Executive VP
No Bio Available
Mr. Elimelech Rosner
Executive VP & CTO
No Bio Available
Mr. Delano Ladd J.D.
Executive VP, General Counsel & Secretary
No Bio Available
Mr. Richard Putnam
Vice President of Investor Relations
No Bio Available
Mr. Steve Lindsay
Executive Vice President of Sales & Relationship Management
No Bio Available
Mr. Brad Bennion
Executive Vice President of Corporate Development & Strategy
No Bio Available
Ms. Tia Padia
Executive VP & Chief Marketing Officer
No Bio Available
Cheryl King
Executive VP & Chief People Officer
No Bio Available

Contacts

Address
UTAH
Draper
15 W Scenic Pointe Dr Ste 100
Contacts
+18017271000.0
healthequity.com